Private Advisor Group’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-34,531
| Closed | -$1.04M | – | 2529 |
|
|
2025
Q1 | $1.04M | Sell |
34,531
-6,142
| -15% | -$201K | 0.01% | 1223 |
|
|
2024
Q4 | $1.42M | Sell |
40,673
-3,114
| -7% | -$116K | 0.01% | 1043 |
|
|
2024
Q3 | $1.75M | Sell |
43,787
-2,639
| -6% | -$123K | 0.01% | 954 |
|
|
2024
Q2 | $2.21M | Sell |
46,426
-1,550
| -3% | -$63.6K | 0.01% | 795 |
|
|
2024
Q1 | $2.08M | Sell |
47,976
-831
| -2% | -$39.6K | 0.01% | 785 |
|
|
2023
Q4 | $2.47M | Buy |
48,807
+189
| +0.4% | +$9.05K | 0.02% | 675 |
|
|
2023
Q3 | $2.21M | Buy |
48,618
+788
| +2% | +$32.5K | 0.02% | 673 |
|
|
2023
Q2 | $1.96M | Sell |
47,830
-637
| -1% | -$24.5K | 0.02% | 728 |
|
|
2023
Q1 | $1.73M | Sell |
48,467
-2,541
| -5% | -$95.4K | 0.02% | 751 |
|
|
2022
Q4 | $1.93K | Sell |
51,008
-58,864
| -54% | -$2.48M | ﹤0.01% | 1120 |
|
|
2022
Q3 | $4.86M | Sell |
109,872
-27,910
| -20% | -$1.18M | 0.06% | 341 |
|
|
2022
Q2 | $5.1M | Sell |
137,782
-19,186
| -12% | -$723K | 0.05% | 399 |
|
|
2022
Q1 | $5.81M | Buy |
156,968
+41,226
| +36% | +$1.35M | 0.04% | 394 |
|
|
2021
Q4 | $3.52M | Buy |
115,742
+71,637
| +162% | +$2.25M | 0.03% | 583 |
|
|
2021
Q3 | $1.48M | Buy |
44,105
+20,664
| +88% | +$779K | 0.01% | 1019 |
|
|
2021
Q2 | $935K | Buy |
23,441
+5,399
| +30% | +$211K | 0.01% | 1096 |
|
|
2021
Q1 | $811K | Buy |
18,042
+3,261
| +22% | +$182K | 0.01% | 1094 |
|
|
2020
Q4 | $836K | Buy |
+14,781
| New | +$737K | 0.01% | 987 |
|
|
2020
Q3 | – | Sell |
-1,309
| Closed | -$77K | – | 2496 |
|
|
2020
Q2 | $77K | Buy |
+1,309
| New | +$72.8K | ﹤0.01% | 1865 |
|
|
2019
Q2 | – | Sell |
-4,360
| Closed | -$354K | – | 1701 |
|
|
2019
Q1 | $354K | Buy |
+4,360
| New | +$281K | 0.01% | 1114 |
|
|
2018
Q4 | – | Sell |
-4,611
| Closed | -$238K | – | 1467 |
|
|
2018
Q3 | $238K | Buy |
+4,611
| New | +$217K | ﹤0.01% | 1354 |
|
|
2018
Q1 | – | Sell |
-4,481
| Closed | -$231K | – | 1262 |
|
|
2017
Q4 | $231K | Sell |
4,481
-489
| -10% | -$26.8K | 0.01% | 992 |
|
|
2017
Q3 | $274K | Sell |
4,970
-132
| -3% | -$6.91K | 0.01% | 1192 |
|
|
2017
Q2 | $263K | Buy |
+5,102
| New | +$238K | 0.01% | 1134 |
|
|
2016
Q1 | – | Sell |
-3,673
| Closed | -$227K | – | 1075 |
|
|
2015
Q4 | $227K | Buy |
+3,673
| New | +$198K | 0.01% | 893 |
|
|
2015
Q3 | – | Sell |
-3,904
| Closed | -$225K | – | 1083 |
|
|
2015
Q2 | $225K | Buy |
+3,904
| New | +$248K | 0.01% | 897 |
|
Other funds holding IONS
BG
DTC
Private Advisor Group's IONS Position: Q2 2025 in Review
Private Advisor Group sold out of Ionis Pharmaceuticals (IONS) in Q2 2025, closing a stake of 34,531 shares — an estimated $1.04M sold.
Private Advisor Group first reported a position in IONS in Q2 2015 and held it in 26 quarters. The position peaked at $5.81M in Q1 2022. 362 funds tracked by Wall St. Rank hold IONS as of Q2 2025.
- Private Advisor Group reported no remaining Ionis Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
- Private Advisor Group sold 34,531 Ionis Pharmaceuticals shares in Q2 2025, an estimated $1.04M.
- Private Advisor Group first reported a position in Ionis Pharmaceuticals in Q2 2015 and held it in 26 quarters.
- Private Advisor Group's Ionis Pharmaceuticals position peaked at $5.81M in Q1 2022.
- 362 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2025.
Based on Private Advisor Group's 13F filing for Q2 2025, filed 11 Aug 2025.